Commentary: Pivoting during a pandemic: developing a new recruitment model for a randomised controlled trial in response to COVID-19
ConclusionWe developed an effective teletrial model which allowed us to complete recruitment at a high rate. The teletrial model is now being used in our other primary care trials as we continue to face the impacts of the COVID-19 pandemic.
Source: Trials - Category: Research Source Type: clinical trials
More News: Aspirin | Australia Health | COVID-19 | Environmental Health | General Practices | Grants | Pandemics | Primary Care | Research | Study